Molecular Genetics of Renal Diseases

Internal Medicine

Volumn 36, Issue 2, 1997, Pages 81-86

  Saito, Akihiko ^a   Yamazaki, Hajime ^a   Nakagawa, Yoichi ^a   Arakawa, Masaaki ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Alport syndrome; Autosomal dominant polycystic kidney disease; Diabetic nephropathy; Experimental renal diseases; IgA nephropathy; Tubular transporter disorders

Indexed keywords

ANIMAL; DIABETIC NEPHROPATHY; GENETICS; GLOMERULONEPHRITIS; HUMAN; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE; MUTATION; NEPHRITIS; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; DIABETIC NEPHROPATHIES; GLOMERULONEPHRITIS; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES; MUTATION; NEPHRITIS, HEREDITARY; POLYCYSTIC KIDNEY DISEASES;

EID: 0031062967     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.81     Document Type: Article

References (73)

1. Gregory MC, Atkin CL. Alport syndrome. In: Diseases of the Kidney. Schrier RW and Gottschalk CW (ed), Little, Brown, pp. 571, 1993.
2. Tryggvason K. Mutations in type IV collagen genes and Alport phenotypes. In: Molecular Pathology and Genetics of Alport Syndrome. Contrib Nephrol 117: 154, 1996.
3. Saito A, Sakatsume M, Yamazaki H, Ogata F, Hirasawa Y, Arakawa M. A deletion mutation in the 3' end of the α5(IV) collagen gene in juvenile-onset Alport syndrome. J Am Soc Nephrol 4: 1649, 1994.
4. Kawai S, Nomura S, Harano T, Harano K, Fukushima T, Osawa G, the Japanese Alport Network. The COL4A5 gene in Japanese Alport syndrome patients: Spectrum of mutations of all exons. Kidney Int 49: 814, 1996.
5. Guo C, Van Damme B, Vanrenterghem Y, Devriendt K, Cassiman JJ, Marynen P. Severe Alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele. J Clin Invest 95: 1832, 1995.
6. Mariyama M, Zheng K, Yang-Feng TL, Reeders ST. Colocalizalion of the genes for the α3(IV) and α4(IV) chains of type IV collagen to chromosome 2 bands q35-q37. Genomics 13: 809, 1992.
7. Mochizuki T, Lemmink HH, Mariyama M, et al. Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 8: 77, 1994.
8. Antignac C, Heidet L. Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis. Contrib Nephrol 117: 172, 1996.
9. Zhou J, Mochizuki T, Smeets H, et al. Deletion of the paired α5(IV) and α6(IV) collagen genes in an inherited smooth muscle cell tumor. Science 261: 1167, 1993.
10. Heidet L, Dahan K, Zhou J, et al. Deletions of both α5(IV) and α6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours. Hum Mol Genet 4: 99, 1995.
11. Hudson BG, Reeders ST, Tryggvason K. Type IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 268: 26033, 1993.
12. Peissel B, Geng L, Kalluri R, et al. Comparative distribution of the α1(IV), α5(IV), and α6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients. J Clin Invest 96: 1948, 1995.
13. Thorner PS, Zheng K, Kalluri R, Jacobs R, Hudson BG. Coordinate gene expression o the α3, α4,and α5 chains of collagen type IV: Evidence from a canine model of X-linked nephritis with a COL4A5 gene mutation. J Biol Chem 271: 13821, 1996.
14. Reeders ST. Molecular genetics of hereditary nephritis. Kidney Int 42: 783, 1992.
15. Savige J. Hereditary abnormalities of renal basement membranes. Pathology 23: 350, 1991.
16. Yamazaki H, Nakagawa Y, Saito A, et al. No linkage to the COL4A3 gene locus in Japanese thin basement membrane disease families. Nephrology 1: 315, 1995.
17. Lemmink HH, Nillesen WN, Mochizuki T, et al. Benign familial hematuria due to mutation of the type IV collagen α4 gene. J Clin Invest 98: 1114, 1996.
18. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 329: 332, 1993.
19. Reeders ST, Breuning MH, Davies KE, et al. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 317: 542, 1985.
20. Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Conolly CJ, Somlo S. Autosomal dominant polycystic kidney disease: Localization of the second gene to chromosome 4q13-q23. Genomics 18: 467, 1993.
21. Peters DJM, Spruit L, Saris JJ, et al. Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat Genet 5: 359, 1993.
22. Daoust MC, Reynolds DM, Bichet DG, Somlo S. Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 25: 733, 1995.
23. de Almeida S, de Almedia E, Peters D, et al. Autosomal dominant polycystic kidney disease: Evidence for the existence of a third locus in a Portuguese family. Hum Genet 96: 83, 1995.
24. The European Polycystic Kidney Disease Consortium. The polycystic kidney disease I gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77: 881, 1994.
25. Burn TC, Connors TD, Dackowski WR, The American PKD1 Consortium (APKDI Consortium). Analysis of the genomic sequence for the autosomal dominant polycyslic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. Hum Mol Genet 4: 575, 1995.
26. The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 81: 289, 1995.
27. Hughes J, Ward CJ, Peral B,et al. The polycystic kidney disease I (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10: 151, 1995.
28. Ward CJ, Turley H, Ong ACM, et al. Polycystin, the polycystic kidney-disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sci USA 93: 1524, 1996.
29. Peters DJM, Spruit L, Klingel R, et al. Adult, fetal, and polycystic kidney expression of polycystin, the polycystic kidney disease-1 gene product. Lab Invest 75: 221, 1996.
30. Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339, 1996.
31. Rosenthal W, Seibold A, Antaramian A, et al. Molecular identification of the gene responsible for congenital nophrogenic diabetes insipidus. Nature 359: 233, 1992.
32. Deen PMT, Verdijk MAJ, Knoers NVAM et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 264: 92, 1994.
33. Fushimi K, Uchida S, Hara Y, Hirata Y, Marumo F, Sasaki S. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature 361: 549, 1993.
34. Canessa CM, Horisberger JD, Rossier BC. Epithelial sodium channel related to proteins involved in neurodegeneration. Nature 361: 467, 1993.
35. + channel is made of three homologous subunits. Nature 367: 463, 1994.
36. Shimkets RA, Warnock DG, Bositis CM, et al. Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 79: 407, 1994.
37. Hansson JH, Nelson-Williams C, Suzuki H, et al. Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 11: 76, 1995.
38. + channel. Cell 83: 969, 1995.
39. Chang SS, Grunder S, Hanukoglu A, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 12: 248, 1996.
40. Gamda G, Saltzberg SN, Lombardi M, et al. Primary structure and functional expression of a cDNA encoding the thiazide-sensitive electroneutral sodium-chloride cotransporter. Proc Natl Acad Sci USA 90: 2749, 1993.
41. Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12: 24, 1996.
42. 2+ on renal function? J Am Soc Nephrol 6: 1530, 1995.
43. Lloyd SE, Pearce SHS, Fisher SE, et al. A common molecular basis from three inherited kidney stone diseases. Nature 379: 445, 1996.
44. Scolari F, Amoroso A, Savoldi S, et al. Familial occurrence of primary glomerulonephritis: evidence for a role of genetic factors. Nephrol Dial Transplant 7: 587, 1992.
45. Rees AJ. The immunogenetics of glomerulonephritis. Kidney Int 45: 377, 1994.
46. Schena FP. Immunogenetic aspects of primary IgA nephropathy. Kidney Int 48: 1998, 1995.
47. Feedman BI, Bowden DW. The role of genetic factors in the development of end-stage renal disease. Curr Opin Nephrol Hypertens 4: 230, 1995.
48. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma levels. Am J Hum Genet 51: 197, 1992.
49. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359: 641, 1992.
50. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342: 1085, 1993.
51. Harden PN, Geddes C, Rowe PA, et al. Polymorphisms in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 345: 1540, 1995.
52. Yoshida H, Mitarai T, Kawamura T, et al. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96: 2162, 1995.
53. Hunley TE, Julian BA, Phillips III JA, et al. Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49: 571, 1996.
54. van Essen GG, Rensma PL, de Zeeuw D, et al. Association between angiotensin-converting enzyme gene polymorphism and failure of renoprotective therapy. Lancet 347: 94, 1996.
55. Marre M, Bernadet P, Gallois Y, et al. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384, 1994.
56. Schmidt S, Schone N, Ritz E, The Diabetic Nephropathy Study Group. Association of ACE gen polymorphism and diabetic nephropathy? Kidney Int 47: 1176, 1995.
57. Dudley CRK, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ. U. K. prospective diabetes study XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 48: 1907, 1995.
58. Yoshida H, Kuriyama S, Atsumi Y, et al. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50: 657, 1996.
59. Hashimoto L, Habita C, Beressi JP, et al. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 371: 161, 1994.
60. Hugot J-P, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379: 821, 1996.
61. Saito A, Pietromonaco S, Loo A K-C, Farquhar MG. Complete cloning and sequencing of rat gp330/"megalin", a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci USA 91: 9725, 1994.
62. Farquhar MG, Saito A, Kerjaschki D, Orlando RA. The Heymann nephritis antigenic complex: Megalin (gp330) and RAP. J Am Soc Nephrol 6: 35, 1995.
63. Saito A, Yamazaki H, Rader K, et al. Mapping rat megalin: The second cluster of the ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis. Proc Natl Acad Sci USA 93: 8601, 1996.
64. Grandaliano G, Choudhury GG, Abboud HE. Transgenic animal models as a tool in the diagnosis of kidney diseases. Semin Nephrol 15: 43, 1995.
65. Weiher H, Noda T, Gray DA, Sharpe AH, Jaenisch R. Transgenic mouse model of kidney disease: Insertional inactivation of ubiquitously expressed gene leads to nephrotic syndrome. Cell 62: 425, 1990.
66. Zwacka RM, Reuter A, Pfaff E, et al. The glomerulosclerosis gene Mpv17 encodes a peroxisomal protein producing reactive oxygen species. EMBO J 13: 5129, 1994.
67. Betsholtz C. Role of platelet-derived growth factors in mouse development. Int J Dev Biol 39: 817, 1995.
68. Noakes PG, Miner JH, Gautam M, Cunningham JM, Sanes JR, Merlie JP. The renal glomerulus of mice lacking s-laminin/laminin β2: nephrosis despite molecular compensation by laminin β1. Nat Genet 10: 400, 1995.
69. Fine LG. Gene transfer into the kidney: Promise for unravelling disease mechanisms, limitations for human gene therapy. Kidney Int 49: 612, 1996.
70. Isaka Y, Brees DK, Ikegaya K, et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 2: 418, 1996.
71. Maser RL, Calvet JP. Analysis of differential gene expression in the kidney by differential cDNA screening, sublractive cloning, and mRNA differential display. Semin Nephrol 15: 29, 1995.
72. Simon DB, Karet FE, Hamdan JM, Di Pietro A, Sanjad SA, Lifton RP. Banter's syndrome, hypokalaemic alkalosis with hypercalciuria. is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13: 183, 1996.
73. + channel, ROMK. Nat Genet 14: 152, 1996.